The Chicago LiverMet Symposium is directed to primary care physicians, medical oncologists, gastroenterologists, surgical oncologists, general surgeons, HPB surgeons, and diagnostic and interventional radiologists. Fellows, residents, and allied health professionals are welcome to participate and will find the program helpful for their everyday practice.
The program offers up-to date presentation of treatment standards by world-class experts based on the presentation of individual cases on each topic, and the practitioners, with a concentrated, concise summary at the end of each talk to discuss how to address the questions practitioners face in clinics and tumor boards.
Upon completion of this activity, attendees should be able to:
- Develop a treatment plan for liver metastases of gastrointestinal and non-gastrointestinal origin, based on disease type and extent
- Discuss the indications and limitations of ablation and resection for patients with colorectal liver metastases
- Develop a plan for conversion/induction chemotherapy for patients with colorectal liver metastases
- Develop a curative strategy for very specific oligometastatic scenarios - go for cure!
In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Rush University Medical Center designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.